PharmaCyte Biotech, Inc. Quarterly Interest Expense in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2023.
  • PharmaCyte Biotech, Inc. Interest Expense for the quarter ending April 30, 2023 was $0.000.
  • PharmaCyte Biotech, Inc. Interest Expense for the twelve months ending April 30, 2023 was $0.000, a 100% decline year-over-year.
  • PharmaCyte Biotech, Inc. annual Interest Expense for 2022 was $0.000, a 100% decline from 2021.
  • PharmaCyte Biotech, Inc. annual Interest Expense for 2021 was $509.000, a 83.3% decline from 2020.
  • PharmaCyte Biotech, Inc. annual Interest Expense for 2020 was $3.05K, a 572% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 $0 $0 Feb 1, 2023 Apr 30, 2023 10-K 2023-07-31
Q4 2022 $0 $0 $0 Nov 1, 2022 Jan 31, 2023 10-Q 2023-03-16
Q3 2022 $0 $0 -$42 -100% Aug 1, 2022 Oct 31, 2022 10-Q 2022-12-14
Q2 2022 $42.00 $0 -$467 -100% May 1, 2022 Jul 31, 2022 10-Q 2022-09-14
Q1 2022 $509 $0 -$1.73K -100% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-31
Q4 2021 $2.24K $0 -$249 -100% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 $2.49K $42.00 -$635 -93.8% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q2 2021 $3.13K $467 +$79.00 +20.4% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 $3.05K $1.73K +$1.28K +282% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-28
Q4 2020 $1.77K $249 +$249 Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $1.52K $677 +$677 Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-14
Q2 2020 $841 $388 +$388 May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $453 $453 Feb 1, 2020 Apr 30, 2020 10-K 2021-08-10
Q4 2019 $0 Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-12
Q3 2019 $0 Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 $0 May 1, 2019 Jul 31, 2019 10-Q 2020-09-11
Q1 2018 $0 $0 -$483 -100% Feb 1, 2018 Apr 30, 2018 10-K 2018-07-20
Q4 2017 $483 $0 -$131 -100% Nov 1, 2017 Jan 31, 2018 10-Q 2018-03-19
Q3 2017 $614 $0 -$356 -100% Aug 1, 2017 Oct 31, 2017 10-Q 2017-12-14
Q2 2017 $970 $0 -$569 -100% May 1, 2017 Jul 31, 2017 10-Q 2017-09-13
Q1 2017 $1.54K $483 +$244 +102% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-20
Q4 2016 $1.3K $131 +$5.00 +3.97% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 $1.29K $356 +$162 +83.5% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q2 2016 $1.13K $569 -$63 -9.97% May 1, 2016 Jul 31, 2016 10-Q 2017-09-13
Q1 2016 $1.19K $239 +$1.54K Feb 1, 2016 Apr 30, 2016 10-K 2017-07-27
Q4 2015 -$353 $126 -$1.39K -91.7% Nov 1, 2015 Jan 31, 2016 10-Q/A 2017-03-13
Q3 2015 $1.04K $194 -$1.88K -90.6% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-02
Q2 2015 $2.92K $632 -$2.02K -76.2% May 1, 2015 Jul 31, 2015 10-Q 2016-09-06
Q1 2015 $4.94K -$1.31K -$3.55K -158% Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 $8.49K $1.52K -$2.24K -59.6% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-08
Q3 2014 $10.7K $2.07K -$1.53K -42.5% Aug 1, 2014 Oct 31, 2014 10-Q/A 2016-01-19
Q2 2014 $12.3K $2.65K -$7.7K -74.4% May 1, 2014 Jul 31, 2014 10-Q/A 2016-01-19
Q1 2014 $20K $2.24K -$34.9K -94% Feb 1, 2014 Apr 30, 2014 10-K 2016-07-29
Q4 2013 $54.8K $3.76K -$220 -5.53% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-13
Q3 2013 $55K $3.61K -$63.7K -94.6% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 $119K $10.4K -$35.7K -77.5% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $154K $37.1K -$157K -80.9% Feb 1, 2013 Apr 30, 2013 10-K/A 2016-01-19
Q4 2012 $312K $3.98K -$31.8K -88.9% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $343K $67.3K +$33.8K +101% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-16
Q2 2012 $310K $46.1K +$79.5K May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 $230K $194K -$114K -37% Feb 1, 2012 Apr 30, 2012 10-K 2013-07-29
Q4 2011 $344K $35.8K +$91.1K Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-26
Q3 2011 $253K $33.4K +$60.1K Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-26
Q2 2011 $193K -$33.4K +$21.5K +39.2% May 1, 2011 Jul 31, 2011 10-Q/A 2011-09-20
Q1 2011 $172K $309K Feb 1, 2011 Apr 30, 2011 10-K 2012-08-14
Q4 2010 -$55.3K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
Q3 2010 -$26.6K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
Q2 2010 -$54.9K May 1, 2010 Jul 31, 2010 10-Q/A 2011-09-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.